CoagulationDisorders near Wesley Chapel, FL

Care Philosophy: Dr Hien Liu is an Associate Member in the Moffitt Cancer Center Department of Blood and Marrow Transplant and Cellular Immunotherapy. She is the Medical Director of the Apheresis Program. She is also an Associate Professor of Oncologic Sciences at the University of South Florida Morsani College of Medicine. Dr Liu received her medical degree from the University of Michigan Medical School. She completed an Internal Medicine Residency at Michigan State University/Grand Rapids Medical Education and Research Center. This was followed by a Hematology/Oncology Fellowship at the Cleveland Clinic Foundation, where she also served as Chief Fellow.

Care Philosophy: Dr Faramand earned her MD from Virginia Commonwealth University School of Medicine in Richmond. She completed an Internal Medicine Residency at the University of Maryland Medical Center, where she also served as Chief Resident. She recently completed a Hematology and Medical Oncology Fellowship at the University of South Florida Morsani College of Medicine and Moffitt Cancer Center, where she also served as Chief Fellow. Dr Faramand's clinical focus is on allogeneic stem cell transplantation for hematologic malignancies. She is particularly interested in improving outcomes for patients with acute leukemias, including acute lymphoblastic leukemias and acute myeloid leukemia as well as myelodysplastic syndrome.

Care Philosophy: Dr Freeman obtained her MD from the National University of Ireland, specialized in hematology at St Bartholomew's in London, and obtained a master's degree in Clinical Drug Development from Queen Mary University of London (QMUL). She also earned her PhD in immuno-oncology and therapeutics from the Barts Cancer Institute of QMUL under Professor John Gribben. She completed a fellowship in lymphoproliferative disorders and joins us from the British Columbia Cancer Agency in Vancouver, Canada, where she served as Assistant Professor and the Myeloma Lead.Dr Freeman's clinical interests are focused on the treatment of patients with plasma cell neoplasms using autologous transplant and cellular immunotherapy.

Care Philosophy: Dr Markowitz is interested in cutaneous oncology and melanoma in particular. He will engage in clinical translational research efforts in tumor immunology and immunotherapy.

Care Philosophy: Dr Vogelbaum is an internationally known leader in neurosurgical oncology and a distinguished investigator in laboratory research, translational and clinical trials in gliomas. Dr Vogelbaum is currently Chief of Neurosurgery and Program Leader of the Department of Neuro-Oncology at Moffitt Cancer Center. He has served on or led numerous scientific committees and holds an array of honors and awards, as well as leadership positions at the regional, national, and international levels. He is the principal investigator and co-investigator of a broad range of early-phase investigator-initiated therapeutic trials, both national and international multisite collaborative studies. He has published over 190 peer-reviewed and invited articles.

Care Philosophy: Dr Aixa Soyano is an Assistant Member in the Department of Breast Oncology. Dr Soyano received her MD degree from Universidad Central de Venezuela/Escuela de Medicina in Venezuela. She completed an Internal Medicine Residency at Steward Saint Elizabeth's Medical Center in Boston, Massachusetts. Dr Soyano recently completed a Hematology Oncology Fellowship at Mayo Clinic in Jacksonville, Florida. Dr Soyano is interested in the multidisciplinary care of patients of any age and race with breast cancer of any stage and subtype. Her research interest is in the future of oncology related to personalized medicine.

Care Philosophy: Dr Piva earned her MD from the University of South Florida, Morsani College of Medicine, where she also completed her Residency in Neurology. She recently completed a Neuro-Oncology Fellowship at Moffitt Cancer Center. Dr Piva has over 40 peer-reviewed publications, has written Investigator Initiated Trials (IIT), and submitted a grant during her Fellowship at Moffitt. Her main clinical and translational research focus will be to develop a program and specialization in onco-neurology. This program will seek to understand, prevent and treat the neurologic complications of immunotherapies such as CAR-T cell Therapy and Immune Checkpoint Inhibitors.

Care Philosophy: Dr Extermann is Program Leader in the Senior Adult Oncology Program at Moffitt Cancer Center. Dr Martine Extermann is also a Professor of Oncology and Medicine at the University of South Florida. She earned her medical degree and a PhD at the University of Geneva, Switzerland. She has a Swiss Board Certification in Internal Medicine, specializing in Hematology-Oncology. She also holds ABIM certifications in Internal Medicine and Medical Oncology. She has worked at Moffitt since 1994 and has been a faculty member since 1997. Her clinical activity and research focus on cancer in older patients.

Care Philosophy: Dr Costa is a Medical Oncologist at the Department of Breast Oncology at Moffitt Cancer Center in the Clinical Investigator Track since 2017. In 2011, Dr Costa completed a Master Degree in Clinical Research at University of Pittsburgh and Clinical Fellowship Training at Allegheny General Hospital, Pittsburgh, Pennsylvania. Dr Costa was an Instructor at the Developmental Therapeutics Program at Northwestern University, Chicago, where he developed early phase clinical trials for the treatment of breast cancer. He has already authored and co-authored over 40 scientific manuscripts.

Care Philosophy: Dr Eroglu is a medical oncologist in the Department of Cutaneous Oncology at Moffitt Cancer Center and an assistant professor in the Department of Oncologic Sciences at the University of South Florida Morsani College of Medicine. Her clinical focus is on treating patients with advanced melanoma and other skin cancers, including basal cell carcinoma and Merkel cell carcinoma, and participating in clinical trials.Dr Eroglu's research interests are translational and clinical research in targeted therapies and combination immunotherapeutics for melanoma and other skin cancers, along with development of personalized treatment strategies and biomarkers for patients with melanoma.

Biography: Dr. Sotomayor is the director of the newly established Cancer Institute at Tampa General Hospital. He is a pioneer in the field of cancer immunology and immunotherapy and an internationally renowned expert in lymphoma research and treatment. Prior to joining Tampa General, he was the director of the George Washington University Cancer Center with responsibility and authority over all aspects of cancer care and research at GW and affiliated health systems. He was also a professor of medicine in the division of hematology/oncology at George Washington University School of Medicine and Health Sciences. Fluent in English and Spanish, Dr. Sotomayor specializes in the treatment of lymphomas and leukemias. The accomplished physician-scientist's ongoing research is directed toward cancer immunology and immunotherapy with special focus in developing novel immune-based approaches for the treatment of lymphomas and other hematologic malignancies. Considered as a world expert in mantle cell lymphoma (MCL), he has more than 140 publications including seminal discoveries published in top tier journals such as Nature Immunology, Nature Medicine, Blood, Proceedings of the National Academy of Sciences, Cancer Cell among others. He has been the recipient of several awards, including the recipient of the National Cancer Institute (NCI) CURE Lifetime Achievement award in 2017. Dr. Sotomayor is involved in several major medical societies and organizations and currently is a member of the Scientific Advisory Board, Lymphoma Research Foundation, member of the Executive Committee of the Mantle Cell Lymphoma Consortium and member of several committees of the American Association for Cancer Research (AACR). He has also served in committees at the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO) and the National Cancer Institute (NCI)

Care Philosophy: Dr James Liu is a neurosurgeon who specializes in the surgical and radiosurgical treatment of brain and spine tumors. Currently, he is an Assistant Member in the Department of Neuro-Oncology at Moffitt Cancer Center and an Assistant Professor of Oncologic Sciences at the University of South Florida. He received his undergraduate education from the University of Michigan. He received a medical degree from Case Western Reserve University School of Medicine. He obtained his residency training in neurosurgery at the Cleveland Clinic. He also completed a post-doctoral fellowship in Cancer Stem Cell Biology at the Cleveland Clinic, during which he was awarded the Congress of Neurological Surgeons Tumor Fellowship.

Care Philosophy: Dr Nishihori is a senior member in the Blood & Marrow Transplant and Cellular Immunotherapy (BMT CI) Department at Moffitt Cancer Center and is a professor in the Department of Oncologic Sciences at the University of South Florida. Dr Nishihori's clinical interests include autologous and allogeneic hematopoietic cell transplantation (HCT) as well as cellular immunotherapeutic approaches for the treatment of various hematologic malignancies including but not limited to multiple myeloma, plasma cell dyscrasias, amyloidosis, malignant lymphomas, acute and chronic leukemias, myelodysplastic syndrome, myelofibrosis and myeloproliferative disorders. He also performs autologous HCT for testicular cancer/germ cell tumor.

Care Philosophy: Dr Richard Kim is a Service Chief of Medical Gastrointestinal Oncology and Senior Member in the Gastrointestinal Oncology Department at Moffitt Cancer Center. He is a Professor of Oncology at the University of South Florida College of Medicine. Dr Kim received his medical degree from the University of Miami School of Medicine and completed a residency in internal medicine at the University of Illinois at Chicago. He pursued a postdoctoral fellowship in hematology and medical oncology at Yale University Comprehensive Cancer Center in New Haven, CT.

Biography: Dr. Richard Tuli, MD is a Radiation Oncology Specialist who practices in Tampa, FL. He is 50 years old. Dr. Richard Tuli, MD is affiliated with Tampa General Hospital and Tampa General Hospital.

Care Philosophy: Dr Jaffer received his MD degree from the University of South Florida, Morsani College of Medicine. He then went on to complete a Neurology Residency at the same institution, serving as the Academic Chief Resident of his program. Most recently, he completed a Clinical Neurophysiology Fellowship, also at the University of South Florida, Morsani College of Medicine. Dr Jaffer's clinical interest is in onco-neurological complications, especially as relates to epilepsy syndromes, myopathies, and neuropathies. He is interested in multimodal clinical research that combines the use of patient parameters with EMG/EEG findings to predict neurologic outcomes and prognosis.

Care Philosophy: Dr Chatwal earned her MD at Florida State University School of Medicine. She completed her Internal Medicine Residency at Emory University School of Medicine, followed by a Hematology Oncology Fellowship at Moffitt Cancer Center and the University of South Florida Morsani College of Medicine. Dr Chatwal's clinical focus is the medical oncology management of patients with genitourinary malignancies, particularly prostate cancer. Her research focus is on prostate cancer clinical trials and outcomes. Dr Chatwal also has a practical and research interest in the important issue of provider burnout.